XML 62 R16.htm IDEA: XBRL DOCUMENT v3.20.1
GOODWILL AND INTANGIBLE ASSETS, NET
12 Months Ended
Dec. 31, 2019
Goodwill and Intangible Assets Disclosure [Abstract]  
GOODWILL AND INTANGIBLE ASSETS, NET GOODWILL AND INTANGIBLE ASSETS, NET
Goodwill

The following table presents the changes in goodwill by segment during 2019 and 2018:
Revlon  Portfolio  Elizabeth Arden  Fragrances  Total  
Balance at January 1, 2018(a)
$265.3  $189.5  $116.9  $120.8  $692.5  
Foreign currency translation adjustment(0.3) (0.3) —  —  (0.6) 
Goodwill impairment charge(a)
—  (18.0) —  —  (18.0) 
Balance at December 31, 2018$265.0  $171.2  $116.9  $120.8  $673.9  
Foreign currency translation adjustment(0.1) (0.1) —  —  (0.2) 
Balance at December 31, 2019$264.9  $171.1  $116.9  $120.8  $673.7  
Cumulative goodwill impairment charges(a)
$(55.2) 
(a) Amount refers to cumulative goodwill impairment charges related to impairments recognized in 2015, 2017 and 2018; no impairment charges were recognized during 2019.

Annual Impairment Testing

For 2019, in assessing whether goodwill was impaired in connection with its annual impairment testing performed during the fourth quarter of 2019 using October 1st, 2019 carrying values, the Company, in accordance with ASC 350, performed qualitative assessments for its (i) Revlon, (ii) Elizabeth Arden Skin and Color and (iii) Fragrances reporting units and a quantitative assessment for its (x) Mass Portfolio, (y) Professional Portfolio and (z) Elizabeth Arden Fragrances reporting units.
In performing the 2019 qualitative assessment, the Company considered, among other factors, the financial performance of each of its Revlon, Elizabeth Arden Skin and Color and Fragrances reporting units, as well as the results of the annual quantitative analysis performed in 2018 for each of these reporting units. Based upon such assessment, the Company determined that it was more likely than not that the fair value of each of its Revlon, Elizabeth Arden Skin and Color and Fragrances reporting units exceeded their respective carrying amounts for 2019.
In performing the 2019 quantitative assessment, the Company used the simplified approach allowed under ASU No. 2017-04, which the Company early adopted as of October 1, 2018, to test its Mass Portfolio, Professional Portfolio and Elizabeth Arden Fragrances reporting units for impairment. Based upon such assessment, the Company determined that it was more likely than not that the fair value of each of its Mass Portfolio, Professional Portfolio and Elizabeth Arden Fragrances reporting units exceeded their respective carrying amounts for 2019.
For 2018, the Company first performed a qualitative assessment on all of its reporting units indicating that indicators of impairment existed for the Mass Portfolio reporting unit within the Portfolio segment. Subsequently, the Company used the simplified approach allowed under ASU No. 2017-04, which the Company early adopted as of October 1, 2018, to test its Mass Portfolio reporting unit for impairment. Following the results of such assessment, the Company recognized an $18.0 million non-cash goodwill impairment charge related to the Mass Portfolio reporting unit within the Portfolio segment in the fourth quarter of 2018. Following the recognition of this non-cash goodwill impairment charge, the Mass Portfolio reporting unit had $54.3 million in remaining goodwill as of December 31, 2018.
Effective January 1, 2018, the Company implemented its brand-centric organizational structure built around its four global brand teams: Revlon; Elizabeth Arden; Portfolio; and Fragrances, which also represent the Company's reporting segments. Following this change in the Company's organizational structure, the Company identified its current six reporting units. Concurrent with the change in reporting segments, goodwill was reassigned to the affected reporting units that had been identified within each reporting segment using a relative fair value allocation approach outlined in ASC 350, using December 31, 2017 carrying values. The Company utilized the two-step process in assessing whether goodwill was impaired for each of the Company's six reporting units and determined that it was more likely than not that the fair values of each of these reporting units exceeded their respective carrying amounts.
Intangible Assets, Net
The following tables present details of the Company's total intangible assets as of December 31, 2019 and December 31, 2018:
December 31, 2019
Gross Carrying Amount  Accumulated Amortization  Net Carrying Amount  Weighted-Average Useful Life (in Years) 
Finite-lived intangible assets:
Trademarks and licenses$271.2  $(110.9) $160.3  13
Customer relationships248.3  (96.5) 151.8  11
Patents and internally-developed intellectual property21.5  (12.1) 9.4  5
Distribution rights31.0  (5.6) 25.4  15
Other1.3  (1.3) —  0
Total finite-lived intangible assets$573.3  $(226.4) $346.9  
Indefinite-lived intangible assets:
Trade names$143.8  N/A  $143.8  
Total indefinite-lived intangible assets$143.8  N/A  $143.8  
Total intangible assets$717.1  $(226.4) $490.7  
December 31, 2018
Gross Carrying Amount  Accumulated Amortization  Net Carrying Amount  Weighted-Average Useful Life (in Years) 
Finite-lived intangible assets:
Trademarks and licenses$272.3  $(94.3) $178.0  13
Customer relationships248.6  (77.9) 170.7  12
Patents and internally-developed intellectual property20.9  (10.1) 10.8  6
Distribution rights31.0  (4.0) 27.0  16
Other1.3  (1.0) 0.3  1
Total finite-lived intangible assets$574.1  $(187.3) $386.8  
Indefinite-lived intangible assets:
Trade names$145.2  N/A  $145.2  
Total indefinite-lived intangible assets$145.2  N/A  $145.2  
Total intangible assets$719.3  $(187.3) $532.0  
Amortization expense for finite-lived intangible assets was $40.3 million and $57.1 million for 2019 and 2018, respectively. The variance was attributable to the accelerated amortization of the Pure Ice intangible assets as a result of the revision of the brand’s intangible assets useful lives following the termination of a business relationship with its principal customer.
In accordance with ASC 360, and in conjunction with the annual impairment testing, the Company reviewed finite-lived intangible assets for impairment. In performing such review, the Company makes judgments about the recoverability of purchased finite lived intangible assets whenever events or changes in circumstances indicate that an impairment may exist. The Company also considers several indicators of impairment, including, among other factors, the following: (i) a significant adverse change in the extent or manner in which a long-lived asset (or asset group) is being used; (ii) a projection or forecast that demonstrates losses associated with the use of a long-lived asset (or asset group); and (iii) whether there exists a current expectation that, more likely than not, a long-lived asset (or asset group) will be sold or otherwise disposed of significantly before the end of its previously estimated useful life. The Company recognizes an impairment if the carrying amount of the long-lived asset group exceeds the Company's estimate of the asset group's undiscounted future cash flows.
Indefinite-lived intangible assets, consisting of certain trade names, were reviewed for the annual impairment assessment during the fourth quarter of 2019 using October 1st carrying values similar to goodwill, in accordance with ASC 350.
For each of 2019 and 2018, no impairment was recognized related to the carrying value of any of the Company's finite or indefinite-lived intangible assets as a result of the annual impairment testing.

The following table reflects the estimated future amortization expense for each period presented, a portion of which is subject to exchange rate fluctuations, for the Company's finite-lived intangible assets as of December 31, 2019:
Estimated Amortization Expense  
2020$34.3  
202133.2  
202232.3  
202330.8  
202427.4  
Thereafter188.9  
Total$346.9